Clinical Trials Browser

Withdrawn × Carcinoma, Renal Cell × Interleukin-2 × Clear all

NCT03111901 2019-07-12

UVA-AM-002

Phase 1/2 Withdrawn

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT02867332 2019-03-06

PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.

Phase 1 Withdrawn

Carcinoma, Renal Cell

NCT03226236 2018-11-13

RENALVax-2

Phase 2 Withdrawn

Carcinoma, Renal Cell, Neoplasm Metastasis